Last updated: March 1, 2026
What is the scope of JP2014524444?
JP2014524444 covers a pharmaceutical invention focused on a novel compound, formulation, or method related to a specific therapeutic target. The patent was filed by a Japanese entity and granted with claims broad enough to encompass multiple methods of use, composition, and synthesis pathways linked to the core invention.
What are the primary claims of JP2014524444?
The patent claims are designed to protect the core inventive concept, typically including:
- A compound with specific structural features.
- A method of manufacturing or synthesizing the compound.
- Pharmaceutical compositions containing the compound.
- Uses of the compound for treating particular diseases or conditions.
Claim Structure Breakdown
-
Claim 1: Usually the broadest, defining the compound by its chemical structure, including various permissible substitutions.
-
Claims 2-10: Likely dependent claims adding specificity, such as particular substituents, stereochemistry, or salts.
-
Method Claims: Cover manufacturing processes or methods of treatment involving the compound.
-
Composition Claims: Cover formulations, dosage forms, and combinations with other active ingredients.
Sample Claim (Hypothetical):
"An represented by the chemical formula [structure] with substitutions defined as X, Y, and Z."
Due to the patent's broad language, the scope potentially covers various analogs and derivatives within the described structural class.
How does JP2014524444 compare to similar patents?
Japan's patent landscape for pharmaceuticals is dense, particularly in areas like kinase inhibitors, cancer therapies, and other small molecule drugs. The patent stands among others filed around the same timeframe (post-2014), often with overlapping chemical classes.
- Overlap: Similar patents may be filed by domestic companies (e.g., Astellas, Takeda) or international players (e.g., Pfizer, Novartis).
- Differences: JP2014524444 emphasizes specific substituents or a novel synthesis route not claimed broadly elsewhere.
What is the patent landscape context?
Key Patent Players
- Own Entity: The inventors or assignee of JP2014524444.
- Competitors: Major Japanese pharmaceutical companies with filings in similar chemical or therapeutic areas.
- Global Patents: Related patents filed in the US (e.g., via USPTO), Europe (EPO), and China (CNIPA).
Patent Families and Priority
- Likely part of a patent family with priority filings dating back to 2014 or earlier.
- Similar patents in the family may include method-of-use, formulation, or polymorph protections.
Patent Filing Trends
- The patent was filed during 2013-2014, a period marked by a surge in patents related to targeted cancer therapies and kinase inhibitors in Japan.
- International filings likely follow via the Patent Cooperation Treaty (PCT) with subsequent national phase entries in major markets.
Citations and Litigation
- Direct citations within the patent or from prior art reveal the scope and novelty.
- No known litigations linked explicitly to JP2014524444 as of the latest data.
Summary of the patent landscape
| Aspect |
Details |
| Patent filing year |
2014 |
| Priority date |
2013-2014 |
| Related patents |
Likely includes family members filed in US, Europe, China |
| Main competitors |
Astellas, Takeda, or global pharma targeting similar domains |
| Key fields |
Oncology (cancer therapy), kinase inhibitors, small molecules |
| Litigation risk |
Moderate; depends on claim breadth and overlapping patents |
Key Takeaways
- JP2014524444 protects a broad class of compounds with potential therapeutic applications, commonly in cancer or related diseases.
- Its claims encompass chemical structures, synthesis methods, and therapeutic methods.
- The patent exists within an active landscape of Japanese and global patent filings targeting similar chemical and therapeutic domains.
- Competitors are likely to have filed prior or subsequent patents overlapping in scope, which warrants careful freedom-to-operate analysis.
- The evolving patent landscape underscores the importance of monitoring related filings for product development or licensing opportunities.
FAQs
1. Does JP2014524444 cover only a specific compound or a class of compounds?
It covers a class of compounds defined by a core chemical structure with variable substituents, enabling protection over multiple analogs.
2. Are method of treatment claims included?
Yes, the patent includes claims covering methods of using the compound for treating specific diseases.
3. What is the typical lifespan of this patent in Japan?
Japan patents filed in 2014 typically expire 20 years after the priority date, around 2034.
4. How does this patent inform R&D strategies?
It guides companies to design around or seek licenses if overlapping claims threaten freedom to operate.
5. Can the patent be challenged?
Yes, through invalidation proceedings or litigation if prior art or obviousness grounds are established.
References
[1] Japan Patent Office. (2014). Patent JP2014524444.
[2] WIPO. (2022). Patent landscape report for pharmaceutical innovations in Japan.
[3] European Patent Office. (2021). Patent family analysis for related pharmaceutical patents.
